Stéphane Postic
Director of Finance/CFO chez MEDINCELL S.A.
Profil
Stéphane Postic is currently the Chief Executive Officer at Da Volterra SA since 2022 and the Chief Financial Officer at MedinCell SA since 2023.
Previously, he worked as a Director at GDSA SA and as the Chief Financial Officer at Genfit SA from 2002 to 2010.
Postes actifs de Stéphane Postic
| Sociétés | Poste | Début |
|---|---|---|
| MEDINCELL S.A. | Director of Finance/CFO | 01/09/2023 |
Da Volterra SA
 Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Chief Executive Officer | 06/09/2022 |
Anciens postes connus de Stéphane Postic
| Sociétés | Poste | Fin |
|---|---|---|
GDSA SA
 GDSA SA Wholesale DistributorsDistribution Services GDSA SA designs and manufactures industrial tools and provides maintenance services and development of processes for the automobile, aeronautics and railway industries. It offers engineering services, tool manufacturing, and on-site tool installation. The company was founded on August 18, 1982 and is headquartered in Saint-Denis, France. | Director/Board Member | - |
| GENFIT | Director of Finance/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GENFIT | Health Technology |
| MEDINCELL S.A. | Health Technology |
| Entreprise privées | 2 |
|---|---|
GDSA SA
GDSA SA Wholesale DistributorsDistribution Services GDSA SA designs and manufactures industrial tools and provides maintenance services and development of processes for the automobile, aeronautics and railway industries. It offers engineering services, tool manufacturing, and on-site tool installation. The company was founded on August 18, 1982 and is headquartered in Saint-Denis, France. | Distribution Services |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Health Technology |
